Named on one round in the feed.
Since 2021-11-05
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
bit.bio A human cell programming company developing technology to produce consistent, scalable human cell models for drug discovery, disease research, functional genomics and toxicology. | Series B Verified against 2 of 3 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $103M | 2021-11-05 | [ PART ] |